A new article in JAMA reports self-blood glucose monitoring for type 2 diabetes is not necessary.
Is there an alternative?
December 18, 2018
Leveraging New Technologies for Better Diabetes Care
January 24, 2017
Diabetes Monitoring and Diagnosis Beyond A1c
January 18, 2017
November is American Diabetes Month
November 28, 2016
Epinex Diagnostics Enters Digital Health Field –Launches “Am I Diabetic” Mobile Phone App
November 17, 2016
November 5, 2012
Here are some facts:
China has an estimated 90 million diabetes sufferers daily.
More than half of China’s diabetics have inadequate blood- glucose control.
As few as two in five diabetics in China have their blood- sugar under control.
According to the IDF, a key difference is that an average of $194 a year is spent treating each diabetes patient in China, versus more than $5,000 in developed countries such as the U.S.
China, unfortunately, has become the world’s capital for diabetes.
A new utility of glycated albumin in monitoring car...
Epinex’s Research Paper Reaches New Milestone
Epinex at the 2017 AACC Conference
Beyond A1C: Glycated Albumin Takes Center Stage at...
Amidst Healthcare Chaos, California Authorizes a Ne...
A new article in JAMA reports self-blood glucose mo...
Plug and Play Tech Center
Asad Zaidi CEO of Epinex Diagnostic Inc. will atten...
Glycated Albumin used in measuring ‘Stress Diabetes...
A potential role of glycated albumin as a marker fo...